# Investigating the Effect of Food on the Bioavailability of a Fixed Dose Combination of Obicetrapib and Ezetimibe

> **NCT06050291** · PHASE1 · COMPLETED · sponsor: **NewAmsterdam Pharma** · enrollment: 28 (actual)

## Conditions studied

- Healthy Volunteer Study

## Interventions

- **DRUG:** Fixed-Dose Combination (FDC) Tablet

## Key facts

- **NCT ID:** NCT06050291
- **Lead sponsor:** NewAmsterdam Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-20
- **Primary completion:** 2024-04-07
- **Final completion:** 2024-04-07
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2024-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06050291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06050291, "Investigating the Effect of Food on the Bioavailability of a Fixed Dose Combination of Obicetrapib and Ezetimibe". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06050291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*